Isolation of the galactose-binding lectin that mediates the in vitro adherence of Entamoeba histolytica.

W A Petri; R D Smith; P H Schlesinger; C F Murphy; J I Ravdin

doi:10.1172/JCI113198

Department of Medicine, University of Virginia, Charlottesville 22908.

Find articles by Petri, W. in: JCI | PubMed | Google Scholar

Department of Medicine, University of Virginia, Charlottesville 22908.

Find articles by Smith, R. in: JCI | PubMed | Google Scholar

Department of Medicine, University of Virginia, Charlottesville 22908.

Find articles by Schlesinger, P. in: JCI | PubMed | Google Scholar

Department of Medicine, University of Virginia, Charlottesville 22908.

Find articles by Murphy, C. in: JCI | PubMed | Google Scholar

Department of Medicine, University of Virginia, Charlottesville 22908.

Find articles by Ravdin, J. in: JCI | PubMed | Google Scholar

Published in Volume 80, Issue 5 on November 1, 1987
J Clin Invest. 1987;80(5):1238–1244. https://doi.org/10.1172/JCI113198.
© 1987 The American Society for Clinical Investigation

Published November 1, 1987 - Version history

Entamoeba histolytica adheres to human colonic mucus, colonic epithelial cells, and other target cells via a galactose (Gal) or N-acetyl-D-galactosamine (GalNAc) inhibitable surface lectin. Blockade of this adherence lectin with Gal or GalNAc in vitro prevents amebic killing of target cells. We have identified and purified the adherence lectin by two methods: affinity columns derivatized with galactose monomers or galactose terminal glycoproteins, and affinity columns and immunoblots prepared with monoclonal antibodies that inhibit amebic adherence. By both methods the adherence lectin was identified as a 170-kD secreted and membrane-bound amebic protein. The surface location of the lectin was confirmed by indirect immunofluorescence. Purified lectin competitively inhibited amebic adherence to target cells by binding to receptors on the target Chinese hamster ovary cells in a Gal-inhibitable manner.

Images.